date,title,source
Nov-14-18,Gritstone Oncology Reports Third Quarter 2018 Financial Results and Recent Business Highlights,GlobeNewswire
Nov-26-18,Here's how much better insiders have profited from this year's IPO boom,American City Business Journals
Dec-10-18,Gritstone Oncology Advances Solid Tumor Bispecific Antibody Program into Lead Optimization Phase; Appoints Vice President of Antibody Therapeutics to Spearhead,GlobeNewswire
Dec-13-18,"Targeting 'bubble baby' disease, this gene therapy company is planting a flag in the East Bay",American City Business Journals
Dec-17-18,"Gritstone Oncology Announces Publication in Nature Biotechnology of Neoantigen Identification Capabilities of its Artificial Intelligence Platform, EDGE",GlobeNewswire
Dec-19-18,"TCR2 Therapeutics Announces Oncology Industry Leader and Expert Andrew Allen, M.D., Ph.D. Joins its Board of Directors",PR Newswire
Dec-20-18,Gritstone Oncology Announces FDA Fast Track Designation for GRANITE-001 for the Treatment of Colorectal Cancer,GlobeNewswire
Dec-28-18,2019 biotech preview: Money is pouring into the Bay Area and so is Big Pharma,American City Business Journals
Jan-03-19,Gritstone Oncology to Present at the 37th Annual J.P. Morgan Healthcare Conference,GlobeNewswire
Feb-27-19,Gritstone Oncology Announces Oral Presentation on MHC Class II Antigen Prediction at the AACR Annual Meeting in April 2019,GlobeNewswire
Mar-05-19,Gritstone Oncology to Present at Two Upcoming Investor Conferences in March,GlobeNewswire
Mar-11-19,"Gritstone Oncology Announces the Appointment of Technology Executive, Mike Forcht, as Senior Vice President of Human Resources to Support Vision for Growth",GlobeNewswire
Mar-21-19,"Gritstone Oncology Announces First Patient Dosed in a Clinical Study Evaluating its Personalized Immunotherapy, GRANITE-001",GlobeNewswire
Mar-25-19,"Health Care Digest: Genentech's tumor-agnostic cancer drug, Novartis' East Bay option and more",American City Business Journals
Mar-28-19,Gritstone Oncology Reports Fourth Quarter and Full Year 2018 Financial Results and Recent Highlights,GlobeNewswire
Apr-02-19,Gritstone Oncology Presents Data at AACR Demonstrating MHC Class II Neoantigen Prediction with EDGE Significantly Outperforms Current Prediction Methods,GlobeNewswire
Apr-03-19,Gritstone Oncology to Present at Needham Healthcare Conference,GlobeNewswire
Apr-03-19,"After inking lease with cancer-fighting company, this new East Bay biotech project is full",American City Business Journals
Apr-04-19,"Gritstone Oncology Announces the Addition of Eugene Zhukovsky, Expert in Bispecific Biotherapeutics Development, to its Scientific Advisory Board",GlobeNewswire
Apr-22-19,Gritstone Oncology Announces Proposed Public Offering of Common Stock,GlobeNewswire
Apr-22-19,Gritstone Oncology Announces Clinical Acceleration of Off-The-Shelf Personalized Neoantigen Immunotherapy Program (SLATE) Following FDA Feedback,GlobeNewswire
Apr-23-19,"The Daily Biotech Pulse: FDA Accepts Alder's Migraine Drug Application, Gritstone Offering, Lilly's Chinese Sale",Benzinga
Apr-24-19,Gritstone Oncology Announces Pricing of $74.8 Million Public Offering of Common Stock,GlobeNewswire
Apr-25-19,Why Gritstone Oncology Stock Is Sinking Today,Motley Fool
Apr-25-19,"The Daily Biotech Pulse: Adverum Gets New CFO, Flexion's Osteoarthritis Trial, Bristol-Myers Earnings",Benzinga
